Home > Insider Trading > Anthera Pharmaceuticals Inc

Anthera Pharmaceuticals Inc (ANTH)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

Market Movers Today: Micron Technology, Inc. (MU), Cogentix Medical Inc. (CGNT), BlueLinx Holdings Inc. (BXC), and More

Micron Technology Inc. MU, +10.22% shares surged Monday after one analyst nearly doubled his price target on the stock. Micron shares rallied nearly 12% to $60.87 at last check.

Keep Reading →

March 12th, 2018 - Market Movers News

13G Filing: Sabby Capital and Anthera Pharmaceuticals Inc (ANTH)

Sabby Healthcare Master Fund, Ltd | 0 | 551,250 | 0 | 551,250 | 551,250 | 3.98 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 03674U300 1.

Keep Reading →

January 9th, 2018 - Hedge Funds

Anthera Pharmaceuticals Inc (ANTH) Looks Good For A Recovery

Anthera Pharmaceuticals Inc (NASDAQ:ANTH) is heading into the close of the year more than 60% down on its early week market cap, on the release of some seemingly disappointing data from one of its lead...

Keep Reading →

December 28th, 2016 - News Stock Analysis

How Anthera Pharmaceuticals Inc (ANTH) Stacks Up Against Its Peers

The worries about the election and the ongoing uncertainty about the path of interest-rate increases have been keeping investors on the sidelines.

Keep Reading →

December 16th, 2016 - Hedge Funds News

Biotech Movers And Shakers: Cascadian Therapeutics Inc (USA) (CASC) And Anthera Pharmaceuticals Inc (ANTH)

Another day done in biotech, and we’re fast closing in on the end of the week.

Keep Reading →

December 8th, 2016 - Market Movers News Stock Analysis

Here's Our Take On The Latest Anthera Pharmaceuticals Inc (ANTH) Numbers

While the wider biotech space was enjoying something of a unexpected return to positive sentiment on Wednesday and Thursday, buoyed by the lifting of the potential investigations into pricing practices...

Keep Reading →

November 11th, 2016 - News Stock Analysis

Here Are Two Biotechs With Catalysts Next Week

It’s going to be a busy quarter for a few companies in the biotech space, with a number of catalysts slated for the next month or so.

Keep Reading →

October 26th, 2016 - News Stock Analysis

Anthera Pharmaceuticals Inc (ANTH): Biotechnology Value Fund Reports 9.99% Stake

Mark Lampert's Biotechnology Value Fund recently filed a Form 13G with the SEC, in which it reported acquiring 4.58 million shares of Anthera Pharmaceuticals Inc (NASDAQ:ANTH), which amass 9.99% of the...

Keep Reading →

September 19th, 2016 - Hedge Funds News

Weak Earnings And Terminated Partnerships, Oh My! Tuesday's Hottest Stocks

Unilife Corp (NASDAQ:UNIS) and Anthera Pharmaceuticals Inc (NASDAQ:ANTH) were among the stocks losing ground early this morning, though one of them has quickly rebounded to turn that frown upside down...

Keep Reading →

September 15th, 2015 - Hedge Funds News

Should You Buy Anthera Pharmaceuticals Inc (ANTH) Following Public Offering Of Common Shares?

In an effort to generate funds for clinical research and development and other general corporate purposes, Anthera Pharmaceuticals Inc (NASDAQ:ANTH) announced earlier today that it is planning to sell...

Keep Reading →

July 9th, 2015 - Hedge Funds News